Leuprolide injectable, camcevi, 1 mg
Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.
CAMCEVI is an Oncology drug manufactured by Accord Healthcare and administered via the Subcutaneous route of administration. The J Code: J1952 is aligned to the drug CAMCEVI.
CAMCEVI is a gonadotropin releasing hormone (GnRH) agonist commonly used to treat advanced prostate cancer. Acting a powerful inhibitor of gonadotropin secretion, long term use of CAMCEVI (J1952) results in a drastic decrease in the amount of testosterone produced. CAMCEVI is used most commonly in men over the age of 65. Patient assistance is available through Camcevi.
January 1, 2022
October 1, 2022